Key Pharmaceuticals Ltd

Successfully developed, registered and launched approximately 25 generic drugs in the UK over ~20 years. Products meet MHRA GMP standards. International presence across six continents. Provides full lifecycle support including formulation, clinical development support for generics, manufacturing scale-up, registration and pharmacovigilance. No novel clinical trial data since focus is on generics. The company acts as a partner for supply of high-quality generics plus regulatory consultancy. Part of Lexon Group which supports wholesaling/retail operations within UK. No direct proprietary drug discovery or innovative therapeutics reported. Pipeline breadth estimated at around dozens (~57 molecules either launched/on application/under development). No specific pipeline program details available publicly.